title: [Selection and characterization of human antibodies against vascular endothelial growth factor from human phage display antibody library].
abstract: OBJECTIVE
  To select anti-VEGF (vascular endothelial growth factor) antibodies (Fab fragments) from human phage display antibody library and to identify their specification and activities.
  
  
  METHODS
  Human immunoglobulin heavy chain and light chain genes were separately amplified by RT-PCR from human peripheral lymphocytes using family specific primers and signal sequences of immunoglobulin. Human antibody library was constructed by phage display technology, and phage Fab antibodies to VEGF were screened from this library. ELISA, Western blot and (3)H-thymidine incorporation assays were used for the specification and neutralization activities of these Fab antibodies. Sequencing analysis was carried out for further identification of the antibodies.
  
  
  RESULTS
  The repertoire of human phage display Fab library was 1.5 x 10(8). After 4 round panning with VEGF(121), 280 clones were checked for their binding activities with ELISA and 12 clones could bind to VEGF(121) specifically. Western blot demonstrated that bacterially expressed soluble Fab could specifically recognize VEGF. Results of (3)H- thymidine incorporation showed that one clone of soluble Fab could neutralize the mitogenic activity of VEGF(165) on HUVEC. Sequencing analysis showed that the obtained V(H) gene belonged to human VH6 subgroup and the light chain was VJC rearranged human VL4 gene.
  
  
  CONCLUSIONS
  Human anti-VEGF antibodies can be obtained from human phage display library, which provides a basis for preparation of high affinity human anti-VEGF monoclonal antibodies through antibody engineer technique.
authors.affiliation: School of Oncology, Beijing Medical University, Beijing Institute for Cancer Research, Beijing 100034, China.
authors.forename: X
authors.initials: X
authors.lastname: Tian
authors.forename: C
authors.initials: C
authors.lastname: Shou
authors.forename: Z
authors.initials: Z
authors.lastname: Dong
mesh_terms: D000906:Antibodies / Q000235:genetics / Q000276:immunology*; D000915:Antibody Affinity; D001435:Bacteriophages / Q000235:genetics; D002460:Cell Line; D003001:Cloning, Molecular; D018076:DNA, Complementary / Q000235:genetics; D016228:Endothelial Growth Factors / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D015723:Gene Library; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000235:genetics / Q000276:immunology; D007143:Immunoglobulin Heavy Chains / Q000235:genetics / Q000276:immunology; D007147:Immunoglobulin Light Chains / Q000235:genetics / Q000276:immunology; D008222:Lymphokines / Q000276:immunology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D000906:Antibodies; D018076:DNA, Complementary; D016228:Endothelial Growth Factors; D007140:Immunoglobulin Fab Fragments; D007143:Immunoglobulin Heavy Chains; D007147:Immunoglobulin Light Chains; D008222:Lymphokines; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors